Sales Success for 193
193, a sales and production company, has achieved extensive sales for four titles from its Cannes slate. The company, an independent joint venture with US Legendary, has secured deals for several films, including Lynne Ramsay’s competitive entry Die, my love.
Die, My Love
Die, my love has been sold to numerous countries, including the Baltics, CIS, Hong Kong, Indonesia, Israel, Japan, the Middle East, Mongolia, the Philippines, Poland, Portugal, and Serbia, Croatia, and Montenegro. Mubi previously acquired the film for North America, Great Britain, Ireland, Latin America, Germany, Austria, Switzerland, Italy, Spain, Benelux, Turkey, India, Australia, and New Zealand in a $24 million deal. Nonstop Entertainment also acquired the Nordic rights.
Scandalous!
193 also sold Scandalous!, Colman Domingo’s directorial debut, to several countries, including Great Britain, Ireland, Italy, Spain, Scandinavia, Australia, New Zealand, the Baltics, Belgium, Greece, Israel, Latin America, Mongolia, the Philippines, Portugal, South Africa, and Turkey.
The Surgeon
Roshan Sethi’s action title The Surgeon, starring Michelle Yeoh, has been sold to Australia, New Zealand, the Baltics, Benelux, CIS, Eastern Europe, Greece, Israel, the Philippines, Portugal, and Turkey.
The Toxic Avenger
Macon Blair’s The Toxic Avenger remake, starring Peter Dinklage, has been sold to Australia, New Zealand, CIS, Germany, Austria, Greece, Israel, Italy, Japan, the Middle East, the Philippines, Poland, South Africa, and Spain. Nonstop acquired the Nordic rights, and Signature Entertainment acquired the film for Great Britain and Ireland.
About the Films
Die, my love is adapted from Ariana Harwicz’s novel and follows a mother struggling to keep her mental health in rural Montana. Scandalous! tells the secret romance between Kim Novak and Sammy Davis Jr. The Surgeon follows a retired surgeon who is kidnapped and forced to operate on a mysterious patient. The Toxic Avenger is a remake of the 1984 classic, following a caretaker who transforms into a mutated vigilante after a freak accident.
Company Statement
"We are very proud that our slate in Cannes is performing so strongly," said 193 CEO Patrick Wachsberger. "Securing global sales for four top-class films confirms the strength of our storytelling and the trust that our global partners have placed in us. This is a fantastic start for our company and a signal for the convincing projects that we will continue to deliver." Legendary and Wachsberger started 193 at the beginning of the year to develop and produce its own features and work on projects with producers and financiers from third-party providers.
